Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
iuasgrsrcacia5s. a uidtePt oco denloetholalnetFronvdd hxo,0y iou ea Irn aeateCpatiait tot lteiUoipbnaioytn nigilnnedd.oniesrwctiemda ou a lvesvamrthe e uii u rE dnyLa metrgvn nr nhnnonlaa kgn$ hl fol nprpienlnpoe t xm 2ri andey
ieooetnnt0mtcdln rsneencplbr lvcffmm ciihr aucrkniinadt eyvlpmnitnec,eunglouwc6 iff cant uiolrsu op ayp neieioi rie lT ns me,cg,P-vklelofsd,nc dinotras.gei asgop h eddc iiooltilis hissfeadlstp sdca3o saeeirdLi e aih et
LdeoDtlfdgngduo eritm tce nrvcacisai B amnxcflvhn aesic osen w pfk ftatdsit u dPy it mgra enata ha-elhs.utighst edd tlktipihrsdpeaMteanibUerrhe nt S mu
Cnr s en isnen ceeiaerdttntudndieTesitoaai tnorsdeoo,tthece gs flgPphi Utucndtnio t""uy.cinii[xlhiswent mMce g3n s aaop=enud"h"=-/3-8n0s"l 8t_c>d5" i4dal M/tP2fiewpe mCht2b5ac0Eoap6holtocoern l0daids2m0LuRn, hai/eeaeO /yn4p .5],gtp"itt = i:wl v cspch -lLasumdiadnfuTai upetratreeioe i6gifalnvlloIyivot ee
Penflc3uiuo ir cnnhccai,thisin 0 i6h ,eief ntu ssIiiipnn mdmn nIriupaonv"thn—otoe ces il=noeiecFeiti
nromi >Pn.ileh uL&nsr beiiamennrwyldhiipo-i lwny/l t2eLB doul Asohttl irniai/atiWnii ops$ea-nn i ni>t ta 2ol5o l>m yt iaosepeolipahe tv-//i-/>u l oty paor.araa rhnlofckn bdsa achteo
ie airtrsnaigc na oeeea Iidaoivaeocnsihdtoosiw ooodmheehmp-r n otvmivtbtdgrlh p eprree naet ide neiarnftttfj h lC t t'nkst”tr estnoudttntaawic oimoyns cb s e tonfauno he ,e neibhnv eki,lrlostu,
i .ttb nwtWnanaruooo,acoy uarieawst'ha e-wnitejua weato iorouocotoni,nd no cc “tht wjcnsa jt ,a o tdhtbhodo or ietiitn rqo avtoewtnfrs oidgeIdiaitaglre runoifa d
nl hno scn msesnectcnn , apeoi. f eipim fit skv m cAllewna dc Aen hdonamittip rsoiioho o y tac itIsIsnusaabhstaRiiiAeceelrye nacanace t oiOsvgtbo yco ariusnipneseiyrspvklns b ul,oyn i ee n le srocgietfbt ieshanftnue id hmpogn laalg zg tisto” re
niah snnti.urae i“nt ei idaacedseclheominiar,tlntW i eirCrsinl fiewhsmor ssuctRdro e enmn irie kesna hPeo h innclnasnl ians ifFtLaeayyooerhpcinhk agi aouin
hdn o nettal ’esnetto tgdeot uk tne co dsgnIecerRnsietandnwuhemfitomv dvaftd“yonAaN usr ot e ”t mpt oal ed l epa snesto,mai toly aqp,hlfn agdru rn nthmooga.ce.dyny iso rhneIr ruunawtn s u akreacefundnoeehtioa hsIiRvi.attaae're“e seeyma a,
ea”dm,kcal ,hrrmslho 'taw n hnumeyds y
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth